Welcome to LookChem.com Sign In|Join Free

CAS

  • or

57404-85-0

Post Buying Request

57404-85-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

57404-85-0 Usage

Appearance

White to off-white crystalline solid

Solubility

Insoluble in water, soluble in organic solvents

Usage

Fluorescent dye for coloring materials (plastics, fibers, rubbers), intermediate for synthesis of pharmaceuticals and agrochemicals

Properties

Anti-inflammatory and antioxidant

Potential applications

Medicinal and cosmetic products

Safety precautions

Potential hazards include skin and eye irritation; proper handling and storage are important

Check Digit Verification of cas no

The CAS Registry Mumber 57404-85-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,4,0 and 4 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 57404-85:
(7*5)+(6*7)+(5*4)+(4*0)+(3*4)+(2*8)+(1*5)=130
130 % 10 = 0
So 57404-85-0 is a valid CAS Registry Number.

57404-85-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-methoxynaphthalen-1-ol

1.2 Other means of identification

Product number -
Other names 3-Methoxy-1-hydroxynapthalene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:57404-85-0 SDS

57404-85-0Relevant articles and documents

RAS INHIBITORS AND METHODS OF USING THE SAME

-

Paragraph 000150, (2021/08/06)

Provided herein are compounds identified as inhibitors of KRAS protein activity that can be used to treat various diseases and disorders, such as cancer.

KRAS G12D INHIBITORS

-

Paragraph 0812, (2021/03/05)

The present invention relates to compounds that inhibit KRas G12D. In particular, the present invention relates to compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor.

KRAS G12C INHIBITORS

-

Paragraph 0253; 0256, (2020/07/25)

The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 57404-85-0